Literature DB >> 26705694

Melanoma antigen-D2: A nucleolar protein undergoing delocalization during cell cycle and after cellular stress.

Céline Pirlot1, Marc Thiry2, Charlotte Trussart1, Emmanuel Di Valentin3, Jacques Piette1, Yvette Habraken4.   

Abstract

Melanoma antigen D2 (MAGE-D2) is recognized as a cancer diagnostic marker; however, it has poorly characterized functions. Here, we established its intracellular localization and shuttling during cell cycle progression and in response to cellular stress. In normal conditions, MAGE-D2 is present in the cytoplasm, nucleoplasm, and nucleoli. Within the latter, MAGE-D2 is mostly found in the granular and the dense fibrillar components, and it interacts with nucleolin. Transfection of MAGE-D2 deletion mutants demonstrated that Δ203-254 leads to confinement of MAGE-D2 to the cytoplasm, while Δ248-254 prevents its accumulation in nucleoli but still allows its presence in the nucleoplasm. Consequently, this short sequence belongs to a nucleolar localization signal. MAGE-D2 deletion does not alter the nucleolar organization or rRNA levels. However, its intracellular localization varies with the cell cycle in a different kinetic than nucleolin. After genotoxic and nucleolar stresses, MAGE-D2 is excluded from nucleoli and concentrates in the nucleoplasm. We demonstrated that its camptothecin-related delocalization results from two distinct events: a rapid nucleolar release and a slower phospho-ERK-dependent cytoplasm to nucleoplasm translocation, which results from an increased flux from the cytoplasm to nucleoplasm. In conclusion, MAGE-D2 is a dynamic protein whose shuttling properties could suggest a role in cell cycle regulation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Camptothecin; Cell cycle; Cellular stress; MAP kinases; Melanoma antigen protein; Nucleolus

Mesh:

Substances:

Year:  2015        PMID: 26705694     DOI: 10.1016/j.bbamcr.2015.12.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

2.  Ultrastructural Localization and Molecular Associations of HCV Capsid Protein in Jurkat T Cells.

Authors:  Cecilia Fernández-Ponce; Maria C Durán-Ruiz; Isaac Narbona-Sánchez; Juan P Muñoz-Miranda; Mikel M Arbulo-Echevarria; Antonio Serna-Sanz; Christian Baumann; Rocío Litrán; Enrique Aguado; Wilhelm Bloch; Francisco García-Cozar
Journal:  Front Microbiol       Date:  2018-01-04       Impact factor: 5.640

3.  Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers.

Authors:  James Ellegate; Michalis Mastri; Emily Isenhart; John J Krolewski; Gurkamal Chatta; Eric Kauffman; Melissa Moffitt; Kevin H Eng
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

4.  A novel MAGED2 variant in a Chinese preterm newborn with transient antenatal Bartter's syndrome with 4 years follow-up.

Authors:  Mingsheng Ma; Mengqi Zhang; Yu Zhou; Fengxia Yao; Min Wei; Zhenghong Li; Zhengqing Qiu
Journal:  BMC Nephrol       Date:  2021-12-11       Impact factor: 2.388

5.  Expression and Prognostic Value of Melanoma-Associated Antigen D2 in Gliomas.

Authors:  Jun Yan; Shenyu Li; Cameron Lenahan; Hainan Chen; Jing Wen; Qianrong Huang; Qian Jiang; Fangzhou Guo; Teng Deng; Ligen Mo
Journal:  Brain Sci       Date:  2022-07-26

6.  Deletion of mdig enhances H3K36me3 and metastatic potential of the triple negative breast cancer cells.

Authors:  Chitra Thakur; Yiran Qiu; Qian Zhang; Nicholas J Carruthers; Miaomiao Yu; Zhuoyue Bi; Yao Fu; Priya Wadgaonkar; Bandar Almutairy; Akimasa Seno; Paul M Stemmer; Fei Chen
Journal:  iScience       Date:  2022-09-03

7.  Integrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer.

Authors:  Wenhua Xue; Lifeng Li; Xin Tian; Zhirui Fan; Ying Yue; Chaoqi Zhang; Xianfei Ding; Xiaoqin Song; Bingjun Ma; Yunkai Zhai; Jingli Lu; Quancheng Kan; Jie Zhao
Journal:  Oncotarget       Date:  2017-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.